For the study, researchers compared the national prevalence of asthma to asthma prevalence among opioid-dependent patients. They also analyzed secondary data of opioid-dependent patients, aged 18 to 79 years at Kings County Hospital Center in New York City between 2013 and 2017.
Researchers found that while the national prevalence of asthma is 8.3 percent, according to the CDC, the prevalence among opioid-dependent patients is 17.2 percent.
Additionally, they found that women are more likely to have asthma according to national estimates — 9.7 percent versus 6.9 percent of men. Twenty-five percent of opioid-dependent women also had asthma.
More articles on opioids:
Purdue Pharma didn’t correct misperceptions about OxyContin strength: 5 notes
Google to tackle opioid epidemic by adding drug disposal locations to Maps
Summa Health’s chief anesthesiologist wants to eliminate opiates from surgeries
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
